BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34043989)

  • 1. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects.
    Ashrafizadeh M; Mirzaei S; Hushmandi K; Rahmanian V; Zabolian A; Raei M; Farahani MV; Goharrizi MASB; Khan H; Zarrabi A; Samarghandian S
    Life Sci; 2021 Aug; 278():119649. PubMed ID: 34043989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.
    Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
    Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma.
    Park IJ; Yang WK; Nam SH; Hong J; Yang KR; Kim J; Kim SS; Choe W; Kang I; Ha J
    Apoptosis; 2014 Apr; 19(4):615-28. PubMed ID: 24173372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
    Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway.
    Wei C; Yao X; Jiang Z; Wang Y; Zhang D; Chen X; Fan X; Xie C; Cheng J; Fu J; Leung EL
    Pharmacol Res; 2019 Jun; 144():79-89. PubMed ID: 30974169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines.
    Shen JJ; Zhan YC; Li HY; Wang Z
    Acta Pharmacol Sin; 2020 Jan; 41(1):110-118. PubMed ID: 31515527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
    Wang ST; Huang SW; Kao JK; Liang SM; Chen YJ; Chen YY; Wu CY; Shieh JJ
    J Dermatol Sci; 2015 May; 78(2):108-16. PubMed ID: 25766763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
    Krishan S; Richardson DR; Sahni S
    Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
    Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
    Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab.
    Li X; Lu Y; Lu H; Luo J; Hong Y; Fan Z
    Oncotarget; 2015 May; 6(13):11507-18. PubMed ID: 25871473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis.
    Jiang S; Shi F; Lin H; Ying Y; Luo L; Huang D; Luo Z
    Int J Biol Macromol; 2020 May; 151():1277-1286. PubMed ID: 31751687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy.
    Wu Y; Si Y; Xiang Y; Zhou T; Liu X; Wu M; Li W; Zhang T; Xiang K; Zhang L; Zhao H; Liu Y
    Arch Biochem Biophys; 2020 Jul; 687():108285. PubMed ID: 32074500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer.
    Han D; Li SJ; Zhu YT; Liu L; Li MX
    Asian Pac J Cancer Prev; 2013; 14(7):4033-9. PubMed ID: 23991948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib.
    Hülsmann HJ; Rolff J; Bender C; Jarahian M; Korf U; Herwig R; Fröhlich H; Thomas M; Merk J; Fichtner I; Sültmann H; Kuner R
    Lung Cancer; 2014 Nov; 86(2):151-7. PubMed ID: 25240516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.